Meet Oxford Capital Partners at the 2007 BioTrinity event

Oxford, UK, 28 February 2007

David Mott, Investment Director at Oxford Capital Partners, the Oxford based venture capital firm focused on science and technology companies, has been invited to Chair a panel discussion at the forthcoming BioTrinity event in Oxford.

The event, which takes place on 27th and 28th March 2007, is the first conference to showcase the best companies from the Oxford and South East of England biotech super-cluster which leads the UK in attracting investment.
During a keynote session of the conference, David Mott will be leading a panel of industry leaders from the US and Europe who have extensive experience in investing in biotechnology and healthcare companies as they discuss how to attract globally focused venture capital investment.

Other panellists include Tim Haines of Abingworth Management Ltd, Nigel Pitchford of 3i and Dr Reinhard Ambros of Novartis Venture Fund.

David commented “Oxford Capital Partners is delighted to be supporting this high profile event, and remain committed to investing in and supporting biotechnology and healthcare firms in the UK.”

With experience of investing in healthcare companies, Oxford Capital Partners is focused on opportunities in the fields of medical devices, medical instruments, diagnostics and services to pharma companies. Recent investments include Oxford Genome Sciences, Sphere Medical, OrthoMimetics, G-Nostics and Veryan Medical.

To see press coverage of the event please click here

Information for editors

Please contact:
Joanne Telford
Oxford Capital Partners
Tel: 01865 860 760
jtelford@oxcp.com
www.oxcp.com

About Oxford Capital Partners

Oxford Capital Partners is a science and technology venture capital firm with extensive experience in investing in and supporting businesses with high growth potential. Oxford Capital Partners looks for the best opportunities, backing exceptional entrepreneurs and investing across all stages of development, from start-up to IPO. Leveraging its extensive networks, Oxford Capital Partners assists portfolio companies in accessing international markets in Europe, the US, Middle East and Asia. Oxford Capital Partners is the manager of four Oxford Gateway Funds and oversees a portfolio of over 25 companies in a range of technology sectors, including ICT, clean technologies, life and physical sciences.

Oxford Capital Partners was named Venture Capital House of the Year 2005 at the Unquote Awards.

Share this page: